Icosavax, Inc. ICVX NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

55/100

3/7 Pass

SharesGrow Intrinsic Value

There have been 50 recent insider transactions recorded for Icosavax, Inc. (ICVX), including 14 buys and 36 sells. Total insider buying was valued at $11.14M and total insider selling at $16.02M.

Notable insiders with recent activity include Fields Heidi, Mcdade Mark, Ra Capital Management, L.p.. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.

Insider Transactions — ICVX

Date	Name	Role	Transaction	Shares	Avg. Price	Value	Shares Owned
2024-02-19	Fields Heidi	Other: See Remarks	Return of Shares	17,000	$9.89	$168.13K	-
2024-02-19	Mcdade Mark	Other: See Remarks	Return of Shares	17,000	$9.89	$168.13K	-
2024-02-19	Ra Capital Management, L.p.	10 Percent Owner	Return of Shares	17,000	$9.89	$168.13K	-
2024-02-19	Veneman Ann M	Other: See Remarks	Return of Shares	25,500	$15.00	$382.5K	-
2024-02-19	Russo Thomas Joseph	Other: See Remarks	Tender Offer (Sell)	39,367	$15.00	$590.51K	-
2024-02-19	Wassil Jim	Other: See Remarks	Return of Shares	17,000	$9.89	$168.13K	-
2024-02-19	Simpson Adam K.	Other: See Remarks	Return of Shares	317,866	$17.55	$5.58M	-
2024-02-19	Cearley Cassia	Other: See Remarks	Return of Shares	89,400	$17.55	$1.57M	-
2024-02-19	Kanesa-thasan Niranjan	Other: See Remarks	Return of Shares	81,950	$17.55	$1.44M	-
2024-02-19	Shiver John W.	Other: See Remarks	Return of Shares	25,500	$22.50	$573.75K	-
2024-02-19	Khan Amin	Other: See Remarks	Return of Shares	180,000	$10.16	$1.83M	-
2024-02-01	Simpson Adam K.	Chief Executive Officer	Option Exercise (Sell)	15,000	$1.04	$15.6K	191,449
2024-01-22	Simpson Adam K.	Chief Executive Officer	Option Exercise (Sell)	4,789	$0.84	$4.02K	-
2024-01-02	Simpson Adam K.	Chief Executive Officer	Informative Sell	15,000	$15.67	$235.09K	260,641
2023-12-21	Simpson Adam K.	Chief Executive Officer	Option Exercise (Sell)	23,343	$0.84	$19.61K	4,789
2023-12-20	Russo Thomas Joseph	Chief Financial Officer	Informative Sell	4,430	$15.47	$68.51K	38,037
2023-12-20	Simpson Adam K.	Chief Executive Officer	Informative Sell	62,205	$15.46	$961.51K	184,724
2023-12-20	Cearley Cassia	Chief Business Officer	Informative Sell	7,934	$15.46	$122.64K	130,694
2023-12-20	Kanesa-thasan Niranjan	Chief Medical Officer	Informative Sell	11,884	$15.46	$183.69K	223,980
2023-12-13	Cearley Cassia	Chief Business Officer	Informative Sell	8,759	$16.01	$140.19K	131,200
2023-08-01	Simpson Adam K.	Chief Executive Officer	Option Exercise (Sell)	3,000	$0.84	$2.52K	28,132
2023-07-31	Russo Thomas Joseph	Chief Financial Officer	Informative Sell	3,066	$8.86	$27.17K	45,620
2023-07-31	Simpson Adam K.	Chief Executive Officer	Informative Sell	11,788	$8.86	$104.46K	243,930
2023-07-31	Cearley Cassia	Chief Business Officer	Informative Sell	1,888	$8.86	$16.73K	139,959
2023-07-31	Kanesa-thasan Niranjan	Chief Medical Officer	Informative Sell	3,323	$8.86	$29.45K	235,864
2023-07-03	Holtzman Douglas	Chief Scientific Officer	Option Exercise (Sell)	16,356	$1.04	$17.01K	28,621
2023-06-12	Khan Amin	EVP, Head of Research & Dev.	Disposition	120,000	$9.06	$1.09M	-
2023-06-12	Khan Amin	EVP, Head of Research & Dev.	RSU Award	180,000	$10.16	$1.83M	180,000
2023-06-06	Fields Heidi	Director	RSU Award	17,000	$9.89	$168.13K	17,000
2023-06-06	Mcdade Mark	Director	RSU Award	17,000	$9.89	$168.13K	17,000
2023-06-06	Ra Capital Management, L.p.	10 Percent Owner	RSU Award	17,000	$9.89	$168.13K	17,000
2023-06-06	Veneman Ann M	Director	RSU Award	17,000	$9.89	$168.13K	17,000
2023-06-06	Wassil Jim	Director	RSU Award	17,000	$9.89	$168.13K	17,000
2023-06-06	Shiver John W.	Director	RSU Award	17,000	$9.89	$168.13K	17,000
2023-05-23	Cearley Cassia	Chief Business Officer	Informative Sell	10,000	$10.00	$100K	141,847
2023-04-03	Holtzman Douglas	Chief Scientific Officer	Option Exercise (Sell)	20,443	$1.04	$21.26K	44,977
2023-03-06	Cearley Cassia	Chief Business Officer	Informative Sell	5,000	$7.75	$38.74K	151,847
2023-02-15	Simpson Adam K.	Chief Executive Officer	Option Exercise	10,677	$1.04	$11.1K	255,718
2023-02-15	Russo Thomas Joseph	Chief Financial Officer	RSU Award	125,000	$9.06	$1.13M	125,000
2023-02-15	Simpson Adam K.	Chief Executive Officer	RSU Award	350,000	$9.06	$3.17M	350,000
2023-02-15	Cearley Cassia	Chief Business Officer	RSU Award	140,000	$9.06	$1.27M	140,000
2023-02-15	Kanesa-thasan Niranjan	Chief Medical Officer	RSU Award	110,000	$9.06	$996.6K	110,000
2023-02-15	Holtzman Douglas	Chief Scientific Officer	RSU Award	90,000	$9.06	$815.4K	90,000
2023-02-15	Bekiroglu Elizabeth	General Counsel & Corp. Sec.	RSU Award	100,000	$9.06	$906K	100,000
2023-02-14	Holtzman Douglas	Chief Scientific Officer	Informative Sell	3,349	$10.17	$34.06K	290,054
2023-02-13	Russo Thomas Joseph	Chief Financial Officer	Informative Sell	1,902	$10.69	$20.34K	48,686
2023-02-13	Simpson Adam K.	Chief Executive Officer	Informative Sell	7,506	$10.69	$80.26K	245,041
2023-02-13	Cearley Cassia	Chief Business Officer	Informative Sell	1,660	$10.69	$17.75K	156,847
2023-02-13	Kanesa-thasan Niranjan	Chief Medical Officer	Informative Sell	1,794	$10.69	$19.18K	239,187
2023-02-13	Holtzman Douglas	Chief Scientific Officer	Informative Sell	1,522	$10.69	$16.27K	293,403

■ Informative Buy/Sell — open market transaction (most significant) ■ Uninformative Buy — award, option exercise, conversion ■ Uninformative Sell — tax withholding, award vest sale ■ Neutral — gift, trust, expiry